학술논문

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study
Document Type
Article
Source
In eClinicalMedicine January 2024 67
Subject
Primary Research
Articles
Language
ISSN
2589-5370